已收盤 02-06 16:00:00 美东时间
-0.130
-0.67%
今日重点评级关注:Needham:维持Vaxcyte"买入"评级,目标价从90美元升至110美元;Citizens: 维持LGI Homes"跑赢大市"评级,目标价从85美元升至95美元
01-08 18:33
今日重点评级关注:HC Wainwright & Co.:维持MetaVia Inc."买入"评级,目标价从12美元升至40美元;Canaccord Genuity:维持GH Research"买入"评级,目标价从35美元升至39美元
01-07 17:25
Keefe, Bruyette & Woods analyst Meyer Shields maintains Fidelis Insurance Hldgs (NYSE:FIHL) with a Outperform and raises the price target from $23 to $24.
01-07 01:32
今日重点评级关注:富国银行:维持Annexon"超配"评级,目标价从14美元升至27美元;瑞穗:上调Relmada Therapeutics评级至"跑赢大市",目标价从1美元升至10美元
2025-11-20 10:28
今日重点评级关注:HC Wainwright & Co.:维持Oncolytics Biotech"买入"评级,目标价从5美元升至10美元;HC Wainwright & Co.:维持Barinthus Biotherapeutics"买入"评级,目标价从3美元升至4美元
2025-11-18 15:28
花旗上调Bilibili目标价升至27美元; 摩根士丹利上调英伟达目标价升至220美元;Ardent Health、Stubhub遭多家大行下调评级>>
2025-11-17 10:49
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
2025-11-14 10:43
Evercore ISI Group analyst David Motemaden maintains Fidelis Insurance Hldgs (NYSE:FIHL) with a In-Line and raises the price target from $19 to $20.
2025-11-13 21:47
Fidelis Insurance Hldgs (NYSE:FIHL) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $1.15 by 4.85 percent. This is a 31.52 percent increase over earnings of $0.92 per share
2025-11-13 05:16
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
2025-11-12 19:11